A woman who did not believe she would live until she was 30 due to a genetic illness affecting her ability to breathe has ...

Learn how to navigate cystic fibrosis care with confidence, from treatments and school plans to building a supportive medical ...

The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained the regulatory nod for four more and become the global leader in the CF market.

This means that the company could potentially treat challenging conditions such as cystic fibrosis. The investment will also support increased domestic biomanufacturing capacity, build on Canadian ...

Babies born with cystic fibrosis — once an early death sentence — can now expect to live long and full lives. A patient diagnosed with cancer in America today is 34% less likely to die from it ...

On March 7, 2025, Vertex Pharmaceuticals announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its ...

Cystic-acne sufferers know that a cyst is not the same beast as your garden-variety pimple. While whitehead pimples sit on the surface of the skin (which, though unsightly, means they’re easier ...

Cystic Fibrosis (CF) is a recessive genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR mutations cause dysregulation of channel function with ...